South Wales, March 16 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "IGLANBA" on Feb. 13. The details about the trademark application no. UK00004340356 published in the journal no. 2026/010 (March 6).
With Bryers Intellectual Property Ltd as representative, Emerge Bioscience Pte. Ltd. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004340356
Disclaimer: Curated by HT Syndication.
